Spain Investigates Metamizole Risks In Expat Britons
Executive Summary
Metamizole is in the safety spotlight again after the Spanish regulator said it was investigating reports of deaths and serious side-effects in expatriate and holidaymaking Britons caused by the painkiller.
You may also be interested in...
Metamizole Safety In Spotlight As EMA Tackles Pregnancy/Lactation Labeling Disarray
More than 50 metamizole-containing medicines are being reviewed by the European Medicines Agency because of substantial differences in their national product labeling regarding dosage and contraindications in pregnant and breastfeeding women.
EU Countries Offered Funding To Contribute to African Regulatory Strengthening
Training projects are intended to strengthen the African regulatory environment, boost the capacity of the African Medicines Agency, facilitate regulatory reliance, and increase joint new drug assessments.
National Drug Stockpiles Create ‘False Sense Of Security’
The generics and biosimilars industry body Medicines for Europe says disparate national stockpiling requirements are not a solution to shortages and can bring “significant risks” for the supply chain and access to medicines.